Leadership Perspectives
Expert insights on inflammation science, clinical translation, and the evolving role of NLRP3 inhibition.
NLRP3 inhibition in PAD
Featuring Marc Bonaca, M.D., M.P.H.
Colchicine and the clinical precedent for upstream intervention
Featuring Jennifer A. Rymer, M.D., M.B.A.
The case for upstream NLRP3 inhibition – safety
Featuring Javed Butler, M.D., M.P.H.
The case for upstream NLRP3 inhibition – efficacy
Featuring Javed Butler, M.D., M.P.H.
hsCRP is a Marker, not a Map
Featuring Naveed Sattar, FMedSci
ZEUS and the Hierarchy of Inflammation
Featuring Kosh Ray, FMedSci